NEW YORK, Nov 17 (Reuters) - Federal prosecutors announced charges on Thursday against two executives in connection with the investigation into drugmaker Valeant Pharmaceuticals (NYSE:VRX) International Inc's VRX.TO secret ties to a specialty pharmacy company.
Gary Tanner, a former Valeant executive, and Andrew Davenport, the former chief executive of specialty pharmacy Philidor Rx Services LLC, were charged in a criminal complaint filed in Manhattan federal court, prosecutors said.